Clinical trials
Phase 2 Hyperphosphatemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 2 |
| Ardelyx | 1 |
| Duke University | 1 |
| Ilypsa | 1 |
| Ineos Healthcare Limited | 1 |
| Keryx Biopharmaceuticals | 1 |
| Nephrian | 1 |
| Novartis Pharmaceuticals | 1 |
| R1 Therapeutics | 1 |
| University of Illinois at Chicago | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphosphatemia | 11 |
| Kidney Failure, Chronic | 5 |
| Renal Insufficiency, Chronic | 4 |
| Kidney Diseases | 3 |
| Renal Insufficiency | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Hypophosphatemia | 1 |
| Inflammation | 1 |
| Pancreatitis | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.